Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies.
暂无分享,去创建一个
S. Libutti | B. Wood | W. Figg | H. Alexander | Z. Neeman | A. Kam | G. Seidel | J. Pingpank | R. Chang | T. Beresneva | B. Wood | S. Zhai | Bradford J. Wood
[1] S. Curley,et al. Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration , 2004, Cancer Chemotherapy and Pharmacology.
[2] J. Berlin,et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Alicia Samuels,et al. Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.
[4] A. Benson,et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. , 2001, Surgery.
[5] L. Schwartz,et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] S. Libutti,et al. Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. , 2000, Journal of the American College of Surgeons.
[7] S. Libutti,et al. Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver. , 2000, The oncologist.
[8] S. Libutti,et al. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] L H Blumgart,et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.
[10] L. Ellis,et al. Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients , 1999 .
[11] D. Fraker,et al. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Doppman,et al. Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] B. Samuels,et al. High-dose intravenous melphalan: a review. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] T. Ravikumar,et al. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] W. Ensminger,et al. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] E. Hall,et al. Interaction of hyperthermia and chemotherapy agents; cell lethality and oncogenic potential. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[17] R. Gray,et al. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study. , 1994, Bone marrow transplantation.
[18] N. Bornfeld,et al. Prognosis and treatment of disseminated uveal melanoma , 1993, Cancer.
[19] S. Curley,et al. Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration. , 1993, Surgery.
[20] R. Glynn,et al. Survival of patients with metastases from uveal melanoma. , 1991, Ophthalmology.
[21] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[22] R. Glynn,et al. Epidemiologic aspects of uveal melanoma. , 1988, Survey of ophthalmology.
[23] J. Ridge,et al. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion. , 1986, Surgery.
[24] C. Karakousis,et al. Survival in metastatic ocular melanoma , 1983, Cancer.
[25] G. Steel,et al. Response of two mouse tumours to hyperthermia with CCNU or melphalan. , 1982, British Journal of Cancer.